Friday, April 09, 2021 4:52:41 PM
"They have admirably managed to eliminate alot of their toxic debt (8-K) in the form of "promissory notes" and they have managed to position themselves with 10 Million in capital in the last 3 months.
A COO has been hired (PR released 2/8/21), one that has an impressive track record and important ties & in-roads. Multiple institutional investors have been brought onboard (PR released 1/27/21 & 4/5/21), and certainly there will be several more within the near future. Multiple manufacturing and production partners have been established (8-K, 10-Q, and prospectus), as well as exposure to several major players in the EV/batteries arena (8-K, 10-Q, and prospectus).
If one wanted to gripe that "dilution" was at the doorstep, that is a real word in this case, because it was actually stated in the 8-K. But right now this company is pushing the right buttons based on what they're being given to work with.
The only thing they lack at this moment is the "official deal", or the approval to up-list, or the patent approval, or the proof of an alternate metal appropriately replacing one of the big two metals in the Hydrolyzer (PR released 3/23/21).
As is, I think this stock should be sitting at the previous high (at least) if it were not for the current predicament that several of the OTC EV stocks are suffering from right now.
So, if you are a long or bull, don't mind any of the contrary narrative. This one is sitting on the precipice of blowing up big! ;)"
Recent NEWH News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:30:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:30:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 09:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:30:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:30:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 10:00:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:30:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 08:05:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:56:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2023 08:15:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 08:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2023 08:30:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM